RMD
Resmed Inc
NYSE · Health Care
$271.63
+4.58 (+1.72%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 5.09B | 4.51B | 19.16B | 19.88B | 18.80B |
| Net Income | 1.38B | 1.10B | 1.09B | 1.22B | 1.24B |
| EPS | — | — | — | — | — |
| Profit Margin | 27.2% | 25.9% | 5.7% | 6.1% | 6.6% |
| Rev Growth | +12.9% | +12.9% | +20.5% | -5.8% | +13.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.99B | 1.99B | 16.00B | 17.00B | 16.78B |
| Total Equity | 17.79B | 17.79B | 19.49B | 22.02B | 19.96B |
| D/E Ratio | 0.11 | 0.11 | 0.82 | 0.77 | 0.84 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.71B | 1.44B | 1.86B | 1.93B | 1.63B |
| Free Cash Flow | — | — | 1.08B | 977.26M | 1.00B |